NEAL KLEIMAN to Quality of Life
This is a "connection" page, showing publications NEAL KLEIMAN has written about Quality of Life.
Connection Strength
0.154
-
Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial. Circ Cardiovasc Interv. 2021 06; 14(6):e010258.
Score: 0.074
-
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv. 2020 02 10; 13(3):323-331.
Score: 0.017
-
Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses. Circ Cardiovasc Interv. 2019 10; 12(10):e008155.
Score: 0.016
-
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovasc Interv. 2017 05 22; 10(10):1034-1044.
Score: 0.014
-
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiol. 2016 11 01; 1(8):945-949.
Score: 0.013
-
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323.
Score: 0.012
-
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80.
Score: 0.007